Viracta(VIRX) - 2018 Q1 - Earnings Call Transcript

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Willie Quinn - Chief Financial Officer & Senior Vice President, Corporate Development Dayton Misfeldt - Interim Chief Executive Officer Judy Fox - Chief Scientific Officer Deepali Suri - Vice President, Clinical Operations Conference Call Participants Marc Frahm - Cowen and Company Hartaj Singh - Oppenheimer Operator Good afternoon, ladies and gentlemen and welcome to the Q1 2019 Sunesis ...